South Korean Biotech Breakthroughs

Results

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

5 companies

AprilBioLtd

Market Cap: ₩1.1t

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.

A397030

₩49,250.00

-12.7%

215.3%

Aimed Bio

Market Cap: ₩3.5t

Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.

A0009K0

₩54,900.00

-12.0%

n/a

3billion

Market Cap: ₩497.4b

Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.

A394800

₩15,660.00

-1.7%

220.9%

Seegene

Market Cap: ₩1.1t

Manufactures and sells molecular diagnostics products worldwide.

A096530

₩23,900.00

-0.4%

-3.2%

ABL Bio

Market Cap: ₩10.9t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

A298380

₩197,500.00

-3.4%

507.7%